Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

Gainers

• Blue Water Vaccines, Inc. BWV shares rose 38.3% to $1.62 in pre-market trading. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business development executive, as Senior Vice President of Marketing and Business Development.
• MDxHealth SA MDXH rose 23.3% to $4.44 in pre-market trading after the company said UnitedHealthcare will provide commercial coverage for the Genomic Prostate Score (GPS) test.
• Fusion Pharmaceuticals Inc. FUSN shares rose 22.8% to $4.46 in pre-market trading as the company announced plans to acquire Phase 2 program for 225Ac-PSMA I&T, a radiopharmaceutical targeting metastatic castrate resistant prostate cancer..
• Palantir Technologies Inc. PLTR rose 17% to $8.90 in pre-market trading after the company reported better-than-expected fourth-quarter financial results. The company also issued first-quarter and FY23 guidance.
• GeoVax Labs, Inc. GOVX rose 15.3% to $0.8999 in pre-market trading.
• China Pharma Holdings, Inc. CPHI rose 13.1% to $0.1096 in pre-market trading after dropping 7% on Monday. China Pharma, during December, announced the launch of N95 medical protective mask.
• Soligenix, Inc. SNGX shares rose 11.5% to $6.51 in pre-market trading. Soligenix recently announced a reverse stock split.
• ContextLogic Inc. WISH rose 9.8% to $0.9650 in pre-market trading. ContextLogic shares jumped over 37% on Monday after Citron Research made bullish comments on the stock on Twitter.
• TMC the metals company Inc. TMC rose 8.6% to $1.13 in pre-market trading after dropping around 5% on Monday. The company, during December, filed prospectus for offering of up to $30 million common shares.
• ContraFect Corporation CFRX rose 8.4% to $0.0698 in pre-market trading after declining around 4% on Monday.

Losers

• T2 Biosystems, Inc. TTOO shares fell 16.4% to $1.17 in pre-market trading after the company reported a proposed public offering and announced results upon completion of the U.S. clinical evaluation for the T2Biothreat Panel.
• Cerberus Cyber Sentinel Corporation CISO shares dropped 13.5% to $0.95 in pre-market trading after the company reported a proposed public offering of common stock.
• Outset Medical, Inc. OM fell 11.8% to $25.06 in pre-market trading after the company reported Q4 results and issued FY23 guidance.
• Guardforce AI Co., Limited GFAI fell 11.8% to $13.67 in pre-market after dropping 18% on Monday. Guardforce AI recently announced a 1-for-40 reverse split.
• Vallon Pharmaceuticals, Inc. VLON fell 7.9% to $0.8105 in pre-market trading after surging 90% on Monday.
• Edible Garden AG Incorporated EDBL fell 7% to $3.83 in pre-market trading after dropping around 8% on Monday. Edible Garden recently announced pricing of an upsized $10.2 million underwritten public offering.
• Sharps Technology, Inc. STSS fell 6.5% to $1.30 in pre-market trading. Sharps Technology recently announced a $3.8 million private placement at $1.69 per share.
• Imperial Petroleum Inc. IMPP shares fell 6.4% to $0.3345 in pre-market trading after jumping over 36% on Monday. The company is scheduled to release its fourth quarter financial results before the market opens on Feb. 15, 2023.
• SHF Holdings, Inc SHFS fell 6.1% to $0.8003 in pre-market trading after gaining 12% on Monday.
• Atreca, Inc. BCEL fell 5.8% to $1.62 in pre-market trading after surging around 14% on Monday. Atreca and Xencor announced plans to develop T Cell engaging bispecific antibody directed against novel solid tumor target.

Now Read This: Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday